All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
LYELL IMMUNOPHARMA, INC. Last Reported: 4/30/2024 Stock Symbol: LYEL

Business Address

201 HASKINS WAY

SOUTH SAN FRANCISCO , CA US 94080

Mailing Address

201 HASKINS WAY

SOUTH SAN FRANCISCO , CA US 94080
Phone Number: 650 695-0677 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 12/31/2018
Cash and Cash Equivalents $125,650,000.00 $286,214,000.00 $224,372,000.00 $109,426,000.00 $116,311,000.00 $205,739,000.00 $293,828,000.00 $393,504,000.00 $564,441,000.00 -- $140,406,000.00 $134,413,000.00 $245,951,000.00 -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $7,865,000.00 $11,423,000.00 $10,662,000.00 $11,629,000.00 $11,613,000.00 $11,214,000.00 $11,492,000.00 $12,226,000.00 $10,317,000.00 -- $4,928,000.00 -- -- -- -- --
Total Current Assets $534,165,000.00 $586,854,000.00 $606,410,000.00 $624,398,000.00 $659,745,000.00 $666,778,000.00 $626,286,000.00 $631,147,000.00 $834,840,000.00 -- $617,547,000.00 -- -- -- -- --
Property Plant and Equipement $97,836,000.00 $108,096,000.00 $113,677,000.00 $118,600,000.00 $125,727,000.00 $127,559,000.00 $120,098,000.00 $115,857,000.00 $109,637,000.00 -- $77,045,000.00 -- -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets $4,238,000.00 $4,423,000.00 $4,520,000.00 $4,602,000.00 $2,914,000.00 $3,712,000.00 $3,483,000.00 $2,669,000.00 $2,791,000.00 -- $2,769,000.00 -- -- -- -- --
Total Assets $694,220,000.00 $794,989,000.00 $835,354,000.00 $880,450,000.00 $977,269,000.00 $1,021,674,000.00 $1,127,406,000.00 $1,198,334,000.00 $1,229,867,000.00 -- $908,280,000.00 -- -- -- -- --
Accounts Payable $4,895,000.00 $4,365,000.00 $5,805,000.00 $5,733,000.00 $4,795,000.00 $4,247,000.00 $3,207,000.00 $3,526,000.00 $4,863,000.00 -- $9,396,000.00 -- -- -- -- --
Accrued Liabilities -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Current Liabilities $91,063,000.00 $97,416,000.00 $98,499,000.00 $96,624,000.00 $157,243,000.00 $153,632,000.00 $197,619,000.00 $211,860,000.00 $207,912,000.00 -- $189,840,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- $1,487,171,000.00 $1,473,639,000.00 -- $41,357,000.00 -- -- -- -- --
Accumulated Other Comprehensive Loss $-404,000.00 $-1,181,000.00 $-2,379,000.00 $-3,879,000.00 $-9,996,000.00 $-8,351,000.00 $-1,623,000.00 $-65,000.00 $73,000.00 -- $256,000.00 -- -- -- -- --
Accumulated Deficit $-1,062,779,000.00 $-949,182,000.00 $-898,329,000.00 $-834,439,000.00 $-759,083,000.00 $-688,829,000.00 $-584,362,000.00 $-500,656,000.00 $-451,781,000.00 -- $-334,143,000.00 -- -- -- -- --
Total Stockholders' Equity $603,157,000.00 $697,573,000.00 $736,855,000.00 $783,826,000.00 $820,026,000.00 $868,042,000.00 $929,787,000.00 $986,474,000.00 $1,021,955,000.00 $-334,048,000.00 $-292,528,000.00 $-266,643,000.00 $-240,109,000.00 $-150,826,000.00 $-111,108,000.00 $850,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $694,220,000.00 $794,989,000.00 $835,354,000.00 $880,450,000.00 $977,269,000.00 $1,021,674,000.00 $1,127,406,000.00 $1,198,334,000.00 $1,229,867,000.00 -- $908,280,000.00 -- -- -- -- --

Statement of Operations

Date 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022 6/30/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020 3/31/2020 12/31/2019 12/31/2018
Total Revenues $3,000.00 $117,000.00 $27,000.00 $65,000.00 $36,297,000.00 $35,741,000.00 $10,650,000.00 $2,755,000.00 $5,073,000.00 -- -- $5,444,000.00 $4,374,000.00 -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $43,174,000.00 $43,849,000.00 $92,101,000.00 $44,630,000.00 $121,156,000.00 $79,549,000.00 $138,693,000.00 $119,408,000.00 $87,975,000.00 -- -- $24,501,000.00 $122,652,000.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $55,578,000.00 $187,617,000.00 $65,932,000.00 $62,621,000.00 $208,571,000.00 $73,002,000.00 $225,426,000.00 $175,066,000.00 $123,150,000.00 -- -- $37,913,000.00 $139,944,000.00 -- -- --
Loss from Operations $-55,575,000.00 $-187,500,000.00 $-128,461,000.00 $-62,556,000.00 $-66,437,000.00 $-105,837,000.00 $-214,776,000.00 $-167,238,000.00 $-118,077,000.00 -- -- $-36,843,000.00 $-135,570,000.00 -- -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.24 $-0.73 $-0.26 $-0.27 $-0.71 $-0.15 $-1.84 -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 254,252,000 251,318,000 250,204,000 249,591,000 246,285,000 246,312,000 135,918 -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.24 $-0.73 $-0.52 $-0.27 $-0.28 $-0.15 $-1.84 -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 254,252,000 250,377,000 250,204,000 249,591,000 248,320,000 245,251,000 135,918 -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 500,000,000 -- 264,905,000 -- -- -- -- --
Common Stock Shares Outstanding 254,927,000 251,869,000 251,026,997 249,609,000 249,240,000 247,109,886 242,738,350 239,789,000 238,549,000 -- 15,570,000 -- -- -- -- --
Common Stock Value $25,000.00 $25,000.00 $25,000.00 $25,000.00 $25,000.00 $25,000.00 $24,000.00 $24,000.00 $24,000.00 -- $2,000.00 -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com